Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-06

FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for a generic Benazepril hydrochloride and hydrochlorothiazide combination tablet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benazepril hydrochloride and hydrochlorothiazide (Benazepril hydrochloride and hydrochlorothiazide)

Snippet

SUPPL AP for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE)